Medical Evidence Blog

This is discussion forum for physicians, researchers, and other healthcare professionals interested in the epistemology of medical knowledge, the limitations of the evidence, how clinical trials evidence is generated, disseminated, and incorporated into clinical practice, how the evidence should optimally be incorporated into practice, and what the value of the evidence is to science, individual patients, and society.

Showing posts with label big pharma. Show all posts
Showing posts with label big pharma. Show all posts
Monday, June 2, 2008

"Off-Label Promotion By Proxy": How the NEJM and Clinical Trials are Used as an Advertising Apparatus. The Case of Aliskiren

›
In the print edition of the June 5th NEJM (mine is delivered almost a week early sometimes), readers will see on the front cover the lead ar...
10 comments:
Monday, March 31, 2008

MRK and SGP: Ye shall know the truth, and the truth shall send thy stock spiralling

›
Apparently, the editors of the NEJM read my blog (even though they stop short of calling for a BOYCOTT): "...it seems prudent to encour...
7 comments:
Friday, January 18, 2008

Have the Peddlers of Antidepressants (Big Pharma) been Successful in Suppressing Negative Trial Results?

›
Yes, according to this article in yesterday's NEJM: http://content.nejm.org/cgi/content/short/358/3/252 Talk about publication bias. Acc...
6 comments:
›
Home
View web version

About Me

My photo
Scott K. Aberegg, M.D., M.P.H.
Professor of Medicine, University of Utah. Former affiliations: Outside Hospital x 7.5 years; Assistant Professor, The Ohio State University; Fellowship & MPH: Johns Hopkins Hospital & Bloomberg School of Public Health, Baltimore, MD; Residency: The University of New Mexico Health Sciences Center; MD: The Ohio State University; BA, Spanish: Miami University, Ohio. All views are my own with NO institutional endorsement.
View my complete profile
Powered by Blogger.